How to Get Semaglutide or Tirzepatide Legally in India: The Prescription Process, Step by Step

Semaglutide and tirzepatide are both fully legal in India with a doctor's prescription. Neither is banned, restricted to hospitals, or limited to diabetes patients: both carry DCGI-approved indications for chronic weight management. The entire process, from first assessment to medicine in hand, takes most people 2 to 5 days and can be done online under India's Telemedicine Practice Guidelines. Here is exactly how it works.

Who qualifies for a prescription

Indian prescribing broadly follows the approved labels: adults with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related condition such as type 2 diabetes, prediabetes, hypertension, PCOS, fatty liver or sleep apnoea. Many Indian doctors reasonably apply lower Asian-Indian BMI cutoffs, since metabolic risk starts earlier in Indian bodies. A doctor also screens for exclusions: pregnancy or planned pregnancy, a personal or family history of medullary thyroid carcinoma or MEN2, history of pancreatitis, and a few others.

The process, step by step

1. 1Health assessment. Share your height, weight, medical history, current medications and goals. Online services do this with a structured intake form; a clinic does it in the consultation itself.
2. 2Baseline blood tests. Most doctors want recent bloodwork before starting: typically HbA1c or fasting glucose, thyroid, liver and kidney function, and a lipid profile. Recent reports (within 3 months) usually suffice; otherwise a home-collection lab visit takes a day.
3. 3Consultation with a registered doctor. Under the Telemedicine Practice Guidelines 2020, a Registered Medical Practitioner can evaluate you over video and prescribe. The doctor confirms eligibility, chooses the molecule and starting dose, and explains side effects and titration.
4. 4The prescription. A valid prescription states the doctor's name and registration number, your name, the drug, dose, frequency and duration, and is signed (digitally is fine). Both medicines start at the lowest dose: 0.25 mg weekly for semaglutide, 2.5 mg weekly for tirzepatide.
5. 5Pharmacy dispensing. Any licensed pharmacy, physical or online, dispenses against the prescription. Injectables ship in cold-chain packaging and go straight into your fridge (2 to 8°C).
6. 6Follow-up and titration. The dose steps up every 4 weeks or slower, based on tolerance. Each escalation is a prescribing decision, so a legitimate service builds in reviews rather than selling you a year of pens upfront.

What it costs through each route

Routes to avoid

• No-prescription sellers. Websites, Telegram channels or Instagram pages shipping pens without a prescription are operating illegally, and counterfeits are common in exactly these channels.
• Compounded or research-grade semaglutide. India's DCGI has not approved compounded GLP-1s; peptide vials sold for research use have no quality assurance and no legal basis for human use.
• Personal imports of foreign pens. With about 35 DCGI-approved brands now sold domestically at lower prices, importing offers no advantage and adds cold-chain and customs risk.
• Someone else's prescription. Dosing is individual, exclusions are real, and pharmacies are required to dispense only to the named patient.

How fast can you realistically start?

With recent blood reports in hand: as fast as 24 to 48 hours from assessment to first injection. Needing fresh labs adds a day or two. The slowest part is usually not the paperwork but the right conversation, making sure the molecule, the dose plan and the budget over 6 to 12 months actually fit you, because a GLP-1 only works for as long as you can sustain it.